iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Option Chain

1,667.2
(-0.51%)
Jul 1, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,400₹0.85 0%26,9500%
--1,440₹0.9 0%47,6000%
00%₹215.3 0%1,480₹1.5 -9.09%2,40,8001174.07%
700100%₹169.15 -17.84%1,500₹2.15 0%4,92,45041.26%
--1,520₹3.15 5%40,95098.30%
--1,540₹4.5 4.65%1,31,950-1.04%
7000%₹118.65 0%1,560₹6.25 5.93%1,05,35014.01%
3500%₹104.7 0%1,580₹8.7 6.74%63,00048.76%
61,6007.97%₹83.3 -8.2%1,600₹12.15 7.04%2,56,900-2.26%
50,40082.27%₹68.55 -9.44%1,620₹16.6 7.09%1,27,4007.05%
66,15022.72%₹54.25 -11.42%1,640₹22.7 7.58%2,00,900-6.36%
1,62,40056.22%₹42.1 -13.28%1,660₹30.35 7.05%2,44,30076.26%
4,45,90021.33%₹31.5 -16.66%1,680₹39.6 5.45%1,97,0503.30%
15,17,95076.94%₹22.6 -20.28%1,700₹50.75 6.72%2,05,450-13.29%
5,18,700-7.72%₹15.8 -22.73%1,720₹62.8 5.54%67,55063.55%
4,95,9503.80%₹11 -24.65%1,740₹77.6 5.29%51,1000%
3,94,450-4.81%₹7.45 -28.36%1,760₹93.9 14.02%19,600-5.08%
1,21,450-0.57%₹5.35 -29.13%1,780--
4,11,95011.14%₹3.65 -31.77%1,800₹129.55 4.72%1,10,2502.60%
64,05039.69%₹2.6 -29.72%1,820--
1,64,500102.58%₹1.65 -36.53%1,840--
67,55027.81%₹1.25 -34.21%1,860--
2,93,6500.47%₹0.6 -50%1,880₹220 0%1,4000%
37,8005.88%₹0.7 -17.64%1,920--

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 16th June 2025
16 Jun 2025|06:23 AM

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection
15 Jun 2025|11:50 PM

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal
24 May 2025|07:51 PM

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore
23 May 2025|12:07 PM

The Board recommended a final dividend of ₹5.50 per share for FY25.

Read More
Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Sun Pharma's Hair Loss Drug Approved by USFDA
26 Jul 2024|01:45 PM

The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.